A detailed history of Alyeska Investment Group, L.P. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 399,578 shares of BDX stock, worth $98.7 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
399,578
Previous 227,484 75.65%
Holding current value
$98.7 Million
Previous $53.2 Million 81.21%
% of portfolio
0.54%
Previous 0.32%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $38.1 Million - $41.7 Million
172,094 Added 75.65%
399,578 $96.3 Million
Q2 2024

Aug 14, 2024

BUY
$225.07 - $246.17 $10.2 Million - $11.1 Million
45,206 Added 24.8%
227,484 $53.2 Million
Q1 2024

May 15, 2024

BUY
$233.45 - $247.73 $19.2 Million - $20.4 Million
82,278 Added 82.28%
182,278 $45.1 Million
Q4 2023

Feb 14, 2024

SELL
$232.24 - $267.23 $34.8 Million - $40.1 Million
-150,000 Reduced 60.0%
100,000 $24.4 Million
Q2 2023

Aug 14, 2023

BUY
$238.39 - $265.32 $59.6 Million - $66.3 Million
250,000 New
250,000 $66 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $33.7 Million - $36.8 Million
146,455 Added 4131.31%
150,000 $37.7 Million
Q1 2020

May 15, 2020

SELL
$195.69 - $279.01 $54.7 Million - $78 Million
-279,647 Reduced 98.75%
3,545 $794,000
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $31.3 Million - $39.5 Million
-152,968 Reduced 35.07%
283,192 $63.8 Million
Q2 2018

Aug 14, 2018

BUY
$208.1 - $233.85 $7.86 Million - $8.83 Million
37,766 Added 9.48%
436,160 $104 Million
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $74.5 Million - $79.2 Million
398,394
398,394 $78.1 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $70.4B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.